Acetylcarnitine

DB08842ApprovedInvestigationalSmall molecule

Acetylcarnitine is an acetylated form of the amino acid derivative L-carnitine that assists in mitochondrial fatty acid metabolism. It is under investigation as a treatment for numerous conditions, including neuropathy, depression, and dementia. Acetylcarnitine is an investigational drug in the United states, Italy, United Kingdom, China, Israel, and Norway, and it is approved in Italy, Portugal, Argentina, Chile, Philippines, Australia, and India.

Chemical structure of Acetylcarnitine
Mechanism
Curator reviewed
Primary indication
Acetylcarnitine is not approved for any indication in the United states and Canada, but it is approved and indicated in Italy for cerebrovascular disorders, mental function disorders, peripheral nerve disorders, diabetic neuropathy, and nutritional supplementation;...Curator reviewed · 3 structured indications
Formula / weight
C9H17NO4 · 203.238 g/mol (avg)
Also known as
acetyl-L-carnitine · O-Acetylcarnitine

Resolves to

Clinical / RWD
Structure
InChIKeyRDHQFKQIGNGIED-MRVPVSSYSA-NSMILESCC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C
Targets

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
2TransportersSubstrate / inhibitor direction, not just membership
Listed above
30Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
1ContraindicationEach with its own population and attribute set
Sign in
37Marketed productsAcross 3 countries and 10 labellers
Sign in
1ATC codeIncluding every combination product, plus 9 drug categories
Sign in
23+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Acetylcarnitine, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account